Risk Of Developing Liver Cancer After HCV Treatment

▼
Sunday, August 26, 2012

Hepatitis C And Clinical Trials

›
Good evening folks, As most of you know, on Thursday Bristol-Myers Squibb announced they were discontinuing a mid-stage study of the e...
Saturday, August 25, 2012

News Ticker-Hepatitis C And Vitamin D, New Hepatitis C Drugs And More

›
  HCV News Ticker       Vitamin D for Your Patients with Chronic Hepatitis C? PII: S0168-8278(12)00602-2 DOI: http://dx.doi.o...
Friday, August 24, 2012

BMS halts the development of BMS-986094 due to patient death

›
Bristol-Myers halts mid-stage study of promising hepatitis C drug Published: Thursday, August 23, 2012, 7:25 PM Updated: Thursday, Augus...
Thursday, August 23, 2012

Hepatitis C Peg/Riba Therapy: With versus Without Fluvastatin-An Open-Label Randomized Controlled Study

›
From Journal of Viral Hepatitis An Open-Label Randomized Controlled Study of Pegylated Interferon/Ribavirin Combination Therapy for Chron...

Medivir Hepatitis C Drug-TMC435(simeprevir) important component in future interferon-free treatments

›
Medivir – Investor relation – Press Release Excerpt- CEO’s comment on the second quarter of 2012 “Good progress in all parts of the...

Occult HBV common in children born to HBsAg-positive mothers despite immunization

›
Occult HBV common in children born to HBsAg-positive mothers despite immunization Shahmoradi S. J Hepatol. 2012;57:515-521. August 23, 2...

Victrelis(boceprevir) - Factors That Predict Response of Patients With Hepatitis C

›
Published on Aug 22, 2012 by AmerGastroAssn Dr. Fred Poordad discusses his manuscript, "Factors That Predict Response of Patient...

Researchers identify gene that disrupts inflammatory process implicated in liver cancer

›
Targeting inflammation to prevent, treat cancers Drs. Anatolij Horuzsko (from left) and Juan Wu look at the molecules that control inflamm...